Phreesia, Inc.
Case Overview
| Lead Plaintiff Deadline: | Lead Plaintiff Deadline: 07/13/2026 |
| Status: | Status: Investigating |
| Company Name: | Company Name: Phreesia, Inc. |
| Ticker: | Ticker: PHR |
| Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
| Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE:PHR) securities during the period of May 8, 2025 through March 30, 2026, inclusive (“the Class Period”).
The lawsuit alleges that the Company made materially false and misleading statements and/or concealing material adverse facts concerning the true state of Phreesia’s slowing demand and reduced visibility in key revenue streams, notably, the weakened pharmaceutical marketing commitments in its Network Solutions segment.
On March 30, 2026, Phreesia announced significantly reduced revenue growth projections for fiscal year 2027 guidance. The Company attributed the shortfall against its prior guidance to a combination of macroeconomic factors including “worsening visibility” and weaker pharmaceutical marketing commitments within its Network Solutions segment. Yet on the third quarter 2026 earnings call on December 8, 2025, CFO Balaji Gandhi had told investors: “For fiscal year 2027, we expect revenue to be in the range of $545 million to $559 million.” On the same call, management described “progress” in the selling season for network solutions. The Company did not reference the visibility challenges. Separately, on September 4, 2025, CEO Chaim Indig stated that the Company’s acquisition of AccessOne Parent Holdings, Inc. (“AccessOne”), a provider of financing solutions for healthcare receivables, would “expand [its] addressable market by roughly $6 billion” and that the combined total addressable market increase would be “approximately $24 billion from approximately $10 billion.” CFO Gandhi projected AccessOne would contribute “approximately $35 million in annualized revenue” to the Company. On this news, the price of Phreesia shares declined by $3.03 per share, or approximately 27%, from $11.41 per share on March 30, 2026 to close at $8.38 on March 31, 2026.